To include your compound in the COVID-19 Resource Center, submit it here.

Mixed Phase II/III PRCS endometriosis results

Praecis (PRCS) said in a double-blind, dose-ranging Phase II/III in 363 premenopausal women with surgically confirmed endometriosis, the percentage

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE